Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.

Podobne zapisy

• Chemotherapy of Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide (DTIC) and Nitrosourea Derivatives (BCNU, CCNU)
  od: Hill, George J., i wsp.
  Wydane: (1974)
• Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma
  od: Yang, Xi, i wsp.
  Wydane: (2010)
• The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
  od: Larsson, P. G., i wsp.
  Wydane: (1979)
• 1-(3-Chloro­phen­yl)-2-methyl-4-nitro-1H-imidazole-5-carboxamide
  od: Korzański, Artur, i wsp.
  Wydane: (2011)
• Post-irradiation sensitization with the ADP-ribosyltransferase inhibitor 3-acetamidobenzamide.
  od: Lunec, J., i wsp.
  Wydane: (1984)